Evidence map›Paper›PMID 30254410›Full record

ArticleWorld journal of gastroenterology2018

Serum anti-

Osamu Toyoshima, Toshihiro Nishizawa, Kosuke Sakitani, Tadahiro Yamakawa, Yoshiyuki Takahashi, Nobutake Yamamichi, Keisuke Hata, Yasuyuki Seto, Kazuhiko Koike, Hidenobu Watanabe and 1 more

Abstract read
In one paragraph

Article in World journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Article
  3. Comparison of GastroPanelJournal of cancer prevention · 2024
    Article
  4. Article
  5. Journal of clinical medicine · 2023
    Article
  6. World journal of gastroenterology · 2023
    Review
  7. [Clinical Application of the Kyoto Classification of Gastritis].The Korean journal of helicobacter and upper gastrointestinal research · 2023
    Review
  8. Pyloric Incompetence Associated withDiagnostics (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Frontiers in immunology · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. What Is New inJournal of clinical medicine · 2021
    Review
  16. Article
  17. A single nucleotide polymorphism inJournal of clinical biochemistry and nutrition · 2021
    Article
  18. JGH open : an open access journal of gastroenterology and hepatology · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Osamu ToyoshimaGastroenterology, Toyoshima Endoscopy Clinic, Tokyo 157-0066, Japan. t@ichou.com.
Toshihiro NishizawaGastroenterology, Toyoshima Endoscopy Clinic, Tokyo 157-0066, Japan.
Kosuke SakitaniGastroenterology, Toyoshima Endoscopy Clinic, Tokyo 157-0066, Japan.
Tadahiro YamakawaGastroenterology, Toyoshima Endoscopy Clinic, Tokyo 157-0066, Japan.
Yoshiyuki TakahashiGastroenterology, Toyoshima Endoscopy Clinic, Tokyo 157-0066, Japan.
Nobutake YamamichiDepartment of Gastroenterology, Graduate School of Medicine, University of Tokyo, Tokyo 113-8655, Japan.
Keisuke HataDepartment of Surgical Oncology, Graduate School of Medicine, University of Tokyo, Tokyo 113-8655, Japan.
Yasuyuki SetoDepartment of Gastrointestinal Surgery, Graduate School of Medicine, University of Tokyo, Tokyo 113-8655, Japan.
Kazuhiko KoikeDepartment of Gastroenterology, Graduate School of Medicine, University of Tokyo, Tokyo 113-8655, Japan.
Hidenobu WatanabePathology and Cytology Laboratory Japan, Tokyo 166-0003, Japan.
Hidekazu SuzukiMedical Education Center, Keio University School of Medicine, Tokyo 160-8582, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo clarify the role of serum anti-

methodsIn this cross-sectional study, the effect of patients' baseline characteristics and endoscopic findings on their serum antibody titers were assessed. We evaluated consecutive patients who underwent esophagogastroduodenoscopy and their first evaluation for

resultsIn total, 874 participants were analyzed with 70%, 16%, 8.7%, and 5.1% of them in the groups A, B, C, and D, respectively. Patients in group C were older than patients in groups A and B. Gastric open-type atrophy, intestinal metaplasia, enlarged folds, diffuse redness, and duodenal ulcers were associated with a high titer. Regular arrangements of collecting venules, fundic gland polyps, superficial gastritis, and gastroesophageal reflux disease were related to a low titer. Multivariate analysis revealed that nodularity (

conclusionSerum antibody titer changes with age, reflects gastric mucosal inflammation, and is useful in predicting the risk of gastric cancer.

Indexed as

AdultAgedAge FactorsAntibodiesAtrophyCross-Sectional StudiesEndoscopy, Digestive SystemFemaleGastric MucosaHelicobacter InfectionsHelicobacter pyloriHumansIntestinal MucosaMaleMetaplasiaMiddle AgedAntibodiesAntibodyEndoscopyGastric cancerGastritisHelicobacter pylori

Identifiers

PMID30254410
PMCPMC6148426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.